Workers strike at Dr. Reddy's API plant; FDA records show angst over execution drug import;

> A strike over wages by nearly 700 contract workers at a Dr. Reddy's API manufacturing plant in Andhra Pradesh, India, continues more than a week after it began. Item

> Documents released by the FDA under the Freedom of Information Act detail how the agency, the Drug Enforcement Administration and the Customs and Border Patrol consulted with the White House to address questions about the legality of the imports and to justify bending the rules to get it to prisons for executions. Story

> Catalent Pharma Solutions says it will acquire the Clinical Trial Supplies business of Aptuit for $410 million. Catalent release

> ASPEX is now providing contract GMP analytical services. Article

> Dial Complete, a hand soap by German manufacturer Henkel, which says that it kills more germs than any other brand, has authorities evaluating the safety of its API, triclosan. Piece

> Chinese drug regulator SFDA is working to strengthen the way it manages drug GMP inspections by standardizing its inspection and certification procedures; step 1: revised requirements for inspectors. Story

> MD Logistics has expanded with a 55,000 square foot facility in Reno, NV, an FDA-registered, GMP-complaint, pharmaceutical-grade warehouse. MD release

> A visual created for new packing of Adcock Ingram's anti-retroviral product range has persuaded drugmaker to adopt it across all its ARV communication material. Story and visual

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.